Dr. Sinha is an experienced synthetic and medicinal chemist. She is working on Gleevec-related projects, creating entirely novel molecules, purifying them and testing them in Alzheimer’s disease animal models. In collaboration with Dr. Bustos, she is also developing compounds for CK1 and autophagy related projects.